Related references
Note: Only part of the references are listed.Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment
Oskar Hansson et al.
NEUROBIOLOGY OF AGING (2010)
Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum
Philip Timmerman et al.
BIOANALYSIS (2010)
Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry
Olivier Heudi et al.
ANALYTICAL CHEMISTRY (2008)
Multidimensional LC separations in shotgun proteomics
Akira Motoyama et al.
ANALYTICAL CHEMISTRY (2008)
Therapeutic potential of gamma-secretase inhibitors and modulators
Bruno P. Imbimbo
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Solid-phase extraction enhances detection of beta-amyloid peptides in plasma and enables Aβ quantification following passive immunization with Aβ antibodies
Thomas A. Lanz et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
Negative ion dissociation of peptides containing hydroxyl side chains
Dan Pu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Determination of β-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry
E Portelius et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Quantification of small therapeutic proteins in plasma by liquid chromatography - Tandem mass spectrometry: Application to an elastase inhibitor EPI-hNE4
F Becher et al.
ANALYTICAL CHEMISTRY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry
Tomoyuki Oe et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease - Prospects, limitations and strategies
Genevieve Evin et al.
CNS DRUGS (2006)
The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications
DS Kirkpatrick et al.
METHODS (2005)
Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: Implications for use in clinical practice
NSM Schoonenboom et al.
CLINICAL CHEMISTRY (2005)
APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42
JA Prince et al.
NEUROLOGY (2004)
Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules
B DeSilva et al.
PHARMACEUTICAL RESEARCH (2003)
CSF markers for incipient Alzheimer's disease
K Blennow et al.
LANCET NEUROLOGY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Analysis of in vivo-derived amyloid-β polypeptides by on-line two-dimensional chromatography-mass spectrometry
NJ Clarke et al.
ANALYTICAL BIOCHEMISTRY (2001)
Amyloid β protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease
PD Mehta et al.
NEUROSCIENCE LETTERS (2001)
Standardization of measurement of β-amyloid(1-42) in cerebrospinal fluid and plasma
H Vanderstichele et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2000)
Proteomics to study genes and genomes
A Pandey et al.
NATURE (2000)
Share Paper
